Guidance for AMAG Pharmaceuticals, Inc. (AMAG)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2020 | N/A | N/A | $225.00M – 255.00M | $250.00M | = Maintained | Details |
| 2020 | N/A | N/A | $230.00M – 280.00M | N/A | = Maintained | Details |
| 2019 | N/A | N/A | $320.00M – 330.00M | $334.95M | = Maintained | Details |
| 2019 | N/A | N/A | $365.00M – 415.00M | $369.17M | = Maintained | Details |
| 2019 | N/A | N/A | $365.00M – 415.00M | $382.51M | = Maintained | Details |
| 2018 | N/A | N/A | $540.00M – 580.00M | $541.80M | = Maintained | Details |
| 2018 | N/A | N/A | $500.00M – 560.00M | $522.80M | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2017 | N/A | N/A | $596.00M – 628.00M | $652.00M | = Maintained | Details |
| 2017 | N/A | N/A | $625.00M – 685.00M | $644.23M | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | N/A | N/A | $523.00M – 553.00M | $543.00M | = Maintained | Details |
| 2016 | N/A | N/A | $503.00M – 553.00M | $533.80M | = Maintained | Details |
| 2015 | N/A | N/A | $425.00M – 450.00M | $444.40M |  Raised |
Details |
| 2015 | N/A | N/A | $395.00M – 430.00M | $397.60M | Raised |
Details |
| 2013 | N/A | N/A | $78.00M – 81.00M | $79.20M | Raised |
Details |
| 2013 | N/A | N/A | $77.00M – 80.00M | N/A | = Maintained | Details |
| 2013 | N/A | N/A | $73.00M – 77.00M | $77.00M | = Maintained | Details |
